A water‐soluble parthenolide analogue suppresses in vivo <i>prostate cancer</i> growth by targeting NFκB and generating reactive oxygen species

Abstract

DMAPT promotes cell death by both generating ROS and inhibition of NFkappaB. Its in vivo activity supports the conduct of clinical trials in patients with castrate-resistant disease.